---
layout: default
title: "MRNA Stock Report"
ticker: "MRNA"
date: 2025-11-15
generated_at: 2025-11-15T09:41:32.995185+00:00
runtime_seconds: 74.51
raw_markdown: |
  **Generated:** <time class="js-local-time" datetime="2025-11-15T09:41:32.995185+00:00">2025-11-15 09:41 UTC</time> (runtime 1m 15s)
  
  ![Moderna, Inc. Common Stock logo](https://ryness.github.io/stonks/assets/logos/MRNA.svg)
  
  
  ## 0. Entry Radar
  
  0.1. **Long Entry?:** maybe — trading near historical lows (1yr 'near-bottom', 5yr 'bottom') and above 7d support 23.04 but still below the 20DMA 25.76 and 7d resistance 27.10; macro froth cues are limited in the provided data
  
  ## 1. The Biz
  
  1.1. **Activities:** Moderna is a commercial-stage biotechnology company developing medicines using mRNA technology, with its covid vaccine authorized in the U.S. in December 2020. It has 35 mRNA development candidates in clinical studies as of August 2025. Programs span infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
  
  1.2. **Profitable?:** No — profitability is negative with a profit margin of -139.6%, sustained net losses (sum -$3.116B), and negative free cash flow; timing to profitability is not provided in the data.
  
  1.3. **Customer & Markets:** unknown
  
  1.4. **Competition:** Primary competitors include Pfizer (PFE), Novavax (NVAX), Johnson & Johnson (JNJ), Merck (MRK), CureVac (CVAC), CRISPR Therapeutics (CRSP), Ocugen (OCGN), and Regeneron (REGN). Relative market positioning or rank among these peers is not specified in the provided data.
  
  ## 2. Recent
  
  2.1. **7d Trend?:** up — price rebounded from the 7d support at 23.04 and closed at 24.77, and the trend label shows 'uptrend'.
  
  2.2. **7d Buy/Sell Points?:** Buying near 23.04 support (suggested buy zone/local low) and selling near 27.10 resistance (suggested sell zone/local high) were favorable levels.
  
  2.3.1. **7d Volume:** med
  
  2.3.2. **7d Volatility:** high
  
  ## 3. Longterm
  
  3.1. **Stability?:** Moderna was founded in 2010 and went public in 2018, indicating a long operating history. Its mRNA platform was validated by U.S. authorization of its covid vaccine in 2020, and it now has 35 clinical-stage programs (as of August 2025). Financials show strain with cumulative net losses (-$3.116B), a -139.6% profit margin, and negative operating and free cash flow (about -$2.0B). Overall, it is an established biotech with a broad pipeline but currently operates with loss-making financials, which is a stability risk.
  
  3.2. **Innovating?:** Innovating — it is advancing 35 mRNA candidates across multiple therapeutic areas, though revenue growth is -45.4% indicating near-term commercial contraction.
  
  ## 4. Context
  
  4.1. **News:** Moderna stopped its CMV vaccine program after a Phase 3 trial failed to meet primary efficacy endpoints. Separately, commentary flagged potential long-term upside from its mRNA platform and the mRNA-4157 cancer vaccine candidate. Sector news from CytomX and Immatics highlights active oncology pipelines but is not specific to Moderna. Quick facts show 'Buy the rumor? no' and 'Sell the news? no', implying limited rumor-driven trading and muted 'sell the news' dynamics around recent developments.
  
  4.2. **Tarrifs:** Tariff impacts appear minimal or indirect, with a Yahoo Finance item listing MRNA among stocks to trade without tariff and rate fears. No company-specific tariff developments are provided in the data.
  
  ## 5. QuickRef
  
  <div class="quickref-table">
  <table>
  <thead><tr><th>Metric</th><th>Answer</th></tr></thead>
  <tbody>
  <tr><td>Last Q4</td><td>$-3.12B</td></tr>
  <tr><td>Price</td><td>24.77</td></tr>
  <tr><td>7d Resistance</td><td>27.10</td></tr>
  <tr><td>7d Support</td><td>23.04</td></tr>
  <tr><td>30d Resistance</td><td>29.45</td></tr>
  <tr><td>30d Support</td><td>23.04</td></tr>
  <tr><td>Buy the dip?</td><td>no</td></tr>
  <tr><td>Buy the rumor?</td><td>no</td></tr>
  <tr><td>Sell the news?</td><td>no</td></tr>
  <tr><td>7d Trend:</td><td>up</td></tr>
  <tr><td>3mo</td><td>middle</td></tr>
  <tr><td>1yr</td><td>near-bottom</td></tr>
  <tr><td>5yr</td><td>bottom</td></tr>
  <tr><td>Overbought/Sold?</td><td>in the middle</td></tr>
  </tbody></table>
  </div>
  
  
  <div class="sources-list">
  <strong>Sources</strong>
  <ul>
  <li>massive.com: company profile &amp; branding, technical indicators, headlines (5 items)</li>
  <li>yfinance: prices &amp; technicals, fundamentals, earnings calendar</li>
  <li>Google Custom Search: core business, product portfolio, profitability, earnings trend, target customers, market segments, competitors, market share, rumors, tariffs news, latest rumor, tariff impact</li>
  <li>The Guardian: business model, profit outlook, market expansion, competitive landscape, rumor, tariff, latest news, tariffs</li>
  </ul>
  </div>
  
  
  <details class="cli-log">
  <summary>Show generation log^</summary>
  <pre><code>
  Gathering context for MRNA...
  Gathering market data...
  Checking massive.com quota and fetching price history...
  Requesting MRNA prices from massive.com... (https://api.massive.com/v2/aggs/ticker/MRNA/range/1/day/2020-10-17/2025-11-15?adjusted=true&amp;sort=asc&amp;limit=5000&amp;apiKey=%2A%2A%2A)
  massive.com request failed (massive.com returned no price data); switching to yfinance...
  Requesting prices from yfinance fallback...
  Price data acquired from yfinance.
  Massive open-close: GET https://api.massive.com/v1/open-close/MRNA/2025-11-14?apiKey=%2A%2A%2A
  Massive open-close: response 200 from https://api.massive.com/v1/open-close/MRNA/2025-11-14?apiKey=&lt;redacted&gt;
  Massive previous close: GET https://api.massive.com/v2/aggs/ticker/MRNA/prev?adjusted=true&amp;apiKey=%2A%2A%2A
  Massive previous close: response 200 from https://api.massive.com/v2/aggs/ticker/MRNA/prev?adjusted=true&amp;apiKey=&lt;redacted&gt;
  Massive SMA: GET https://api.massive.com/v1/indicators/sma/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
  Massive SMA: response 200 from https://api.massive.com/v1/indicators/sma/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
  Massive EMA: GET https://api.massive.com/v1/indicators/ema/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
  Massive EMA: response 200 from https://api.massive.com/v1/indicators/ema/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
  Massive MACD: GET https://api.massive.com/v1/indicators/macd/MRNA?timespan=day&amp;series_type=close&amp;fast=12&amp;slow=26&amp;signal=9&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
  Massive MACD: response 429 from https://api.massive.com/v1/indicators/macd/MRNA?timespan=day&amp;series_type=close&amp;fast=12&amp;slow=26&amp;signal=9&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
  Massive RSI: GET https://api.massive.com/v1/indicators/rsi/MRNA?timespan=day&amp;window=14&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
  Massive RSI: response 429 from https://api.massive.com/v1/indicators/rsi/MRNA?timespan=day&amp;window=14&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
  Calculating technical snapshot...
  Fetching company profile (massive.com)...
  Massive profile: GET https://api.massive.com/v3/reference/tickers/MRNA?apiKey=%2A%2A%2A
  Massive profile: response 200 from https://api.massive.com/v3/reference/tickers/MRNA?apiKey=&lt;redacted&gt;
  Massive profile: company metadata retrieved successfully.
  Massive logo: using cached asset /home/runner/work/stonks/stonks/assets/logos/MRNA.svg
  Massive related companies: GET https://api.massive.com/v1/related-companies/MRNA?apiKey=%2A%2A%2A
  Massive related companies: response 200 from https://api.massive.com/v1/related-companies/MRNA?apiKey=&lt;redacted&gt;
  Massive related companies: retrieved 10 entries.
  Fetching company fundamentals...
  Retrieving earnings calendar...
  Massive earnings: attempting request with key 2QGS***XN
  Massive earnings: GET https://api.massive.com/benzinga/v1/earnings?ticker=MRNA&amp;limit=4&amp;apiKey=%2A%2A%2A
  Massive earnings: response 403 from https://api.massive.com/benzinga/v1/earnings?ticker=MRNA&amp;limit=4&amp;apiKey=&lt;redacted&gt;
  Massive earnings: access denied (403) - You are not entitled to this data. Please upgrade your plan at https://polygon.io/pricing
  Assembling quick facts...
  Collecting latest headlines (massive.com)...
  Massive news: GET https://api.massive.com/v2/reference/news?ticker=MRNA&amp;limit=5&amp;order=desc&amp;apiKey=%2A%2A%2A
  Massive news: response 200 from https://api.massive.com/v2/reference/news?ticker=MRNA&amp;limit=5&amp;order=desc&amp;apiKey=&lt;redacted&gt;
  Massive news: collected 5 articles.
    massive.com returned 5 headlines
  Running supplementary searches...
    google_custom_search search -&gt; MRNA core business (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+core+business&amp;num=5
      google_custom_search: 5 result(s)
    google_custom_search search -&gt; MRNA product portfolio (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+product+portfolio&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA business model (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+business+model&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA business model&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+business+model&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA business model&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+business+model&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA profitability (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+profitability&amp;num=5
      google_custom_search: 5 result(s)
    google_custom_search search -&gt; MRNA earnings trend (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+earnings+trend&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA profit outlook (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+profit+outlook&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA profit outlook&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+profit+outlook&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA profit outlook&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+profit+outlook&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA target customers (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+target+customers&amp;num=5
      google_custom_search: 5 result(s)
    google_custom_search search -&gt; MRNA market segments (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+market+segments&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA market expansion (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+market+expansion&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA market expansion&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+market+expansion&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA market expansion&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+market+expansion&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA competitors (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+competitors&amp;num=5
      google_custom_search: 5 result(s)
    google_custom_search search -&gt; MRNA market share (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+market+share&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA competitive landscape (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+competitive+landscape&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA competitive landscape&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+competitive+landscape&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA competitive landscape&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+competitive+landscape&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA rumors (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+rumors&amp;num=5
      google_custom_search: 5 result(s)
    google_custom_search search -&gt; MRNA tariffs news (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+tariffs+news&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA rumor (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+rumor&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA rumor&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+rumor&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA rumor&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+rumor&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    newsapi search -&gt; MRNA tariff (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+tariff&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA tariff&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+tariff&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA tariff&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+tariff&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    newsapi search -&gt; MRNA latest news (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+latest+news&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA latest news&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+latest+news&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA latest news&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+latest+news&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA latest rumor (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+latest+rumor&amp;num=5
      google_custom_search: 5 result(s)
    newsapi search -&gt; MRNA tariffs (priority: newsapi, gnews, guardian)
  NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+tariffs&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
  NewsAPI search failed for &#x27;MRNA tariffs&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
  GNews search: GET https://gnews.io/api/v4/search?q=MRNA+tariffs&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
  GNews search failed for &#x27;MRNA tariffs&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
  Guardian search: GET https://content.guardianapis.com/search?q=MRNA+tariffs&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
      newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
      gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
      guardian: 5 result(s)
    google_custom_search search -&gt; MRNA tariff impact (priority: google_custom_search, newsapi, gnews, guardian)
  Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+tariff+impact&amp;num=5
      google_custom_search: 5 result(s)
  Synthesizing narrative from OpenAI response...
  Preparing OpenAI request...
  Dispatching bullets to OpenAI:
    - 0.1 Long Entry? [Lead with &#x27;yes&#x27;, &#x27;no&#x27;, or &#x27;maybe&#x27;, then cite specific historical positioning, macro froth cues (or lack thereof), and placement relative to moving averages or support/resistance.]
    - 1.1 Activities
    - 1.2 Profitable?
    - 1.3 Customer &amp; Markets
    - 1.4 Competition
    - 2.1 7d Trend?
    - 2.2 7d Buy/Sell Points?
    - 2.3.1 7d Volume
    - 2.3.2 7d Volatility
    - 3.1 Stability?
    - 3.2 Innovating?
    - 4.1 News
    - 4.2 Tarrifs
  Asking OpenAI for analysis...
  Received response from OpenAI.
  </code></pre>
  </details>
---

**Generated:** <time class="js-local-time" datetime="2025-11-15T09:41:32.995185+00:00">2025-11-15 09:41 UTC</time> (runtime 1m 15s)

![Moderna, Inc. Common Stock logo](https://ryness.github.io/stonks/assets/logos/MRNA.svg)


## 0. Entry Radar

0.1. **Long Entry?:** maybe — trading near historical lows (1yr 'near-bottom', 5yr 'bottom') and above 7d support 23.04 but still below the 20DMA 25.76 and 7d resistance 27.10; macro froth cues are limited in the provided data

## 1. The Biz

1.1. **Activities:** Moderna is a commercial-stage biotechnology company developing medicines using mRNA technology, with its covid vaccine authorized in the U.S. in December 2020. It has 35 mRNA development candidates in clinical studies as of August 2025. Programs span infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

1.2. **Profitable?:** No — profitability is negative with a profit margin of -139.6%, sustained net losses (sum -$3.116B), and negative free cash flow; timing to profitability is not provided in the data.

1.3. **Customer & Markets:** unknown

1.4. **Competition:** Primary competitors include Pfizer (PFE), Novavax (NVAX), Johnson & Johnson (JNJ), Merck (MRK), CureVac (CVAC), CRISPR Therapeutics (CRSP), Ocugen (OCGN), and Regeneron (REGN). Relative market positioning or rank among these peers is not specified in the provided data.

## 2. Recent

2.1. **7d Trend?:** up — price rebounded from the 7d support at 23.04 and closed at 24.77, and the trend label shows 'uptrend'.

2.2. **7d Buy/Sell Points?:** Buying near 23.04 support (suggested buy zone/local low) and selling near 27.10 resistance (suggested sell zone/local high) were favorable levels.

2.3.1. **7d Volume:** med

2.3.2. **7d Volatility:** high

## 3. Longterm

3.1. **Stability?:** Moderna was founded in 2010 and went public in 2018, indicating a long operating history. Its mRNA platform was validated by U.S. authorization of its covid vaccine in 2020, and it now has 35 clinical-stage programs (as of August 2025). Financials show strain with cumulative net losses (-$3.116B), a -139.6% profit margin, and negative operating and free cash flow (about -$2.0B). Overall, it is an established biotech with a broad pipeline but currently operates with loss-making financials, which is a stability risk.

3.2. **Innovating?:** Innovating — it is advancing 35 mRNA candidates across multiple therapeutic areas, though revenue growth is -45.4% indicating near-term commercial contraction.

## 4. Context

4.1. **News:** Moderna stopped its CMV vaccine program after a Phase 3 trial failed to meet primary efficacy endpoints. Separately, commentary flagged potential long-term upside from its mRNA platform and the mRNA-4157 cancer vaccine candidate. Sector news from CytomX and Immatics highlights active oncology pipelines but is not specific to Moderna. Quick facts show 'Buy the rumor? no' and 'Sell the news? no', implying limited rumor-driven trading and muted 'sell the news' dynamics around recent developments.

4.2. **Tarrifs:** Tariff impacts appear minimal or indirect, with a Yahoo Finance item listing MRNA among stocks to trade without tariff and rate fears. No company-specific tariff developments are provided in the data.

## 5. QuickRef

<div class="quickref-table">
<table>
<thead><tr><th>Metric</th><th>Answer</th></tr></thead>
<tbody>
<tr><td>Last Q4</td><td>$-3.12B</td></tr>
<tr><td>Price</td><td>24.77</td></tr>
<tr><td>7d Resistance</td><td>27.10</td></tr>
<tr><td>7d Support</td><td>23.04</td></tr>
<tr><td>30d Resistance</td><td>29.45</td></tr>
<tr><td>30d Support</td><td>23.04</td></tr>
<tr><td>Buy the dip?</td><td>no</td></tr>
<tr><td>Buy the rumor?</td><td>no</td></tr>
<tr><td>Sell the news?</td><td>no</td></tr>
<tr><td>7d Trend:</td><td>up</td></tr>
<tr><td>3mo</td><td>middle</td></tr>
<tr><td>1yr</td><td>near-bottom</td></tr>
<tr><td>5yr</td><td>bottom</td></tr>
<tr><td>Overbought/Sold?</td><td>in the middle</td></tr>
</tbody></table>
</div>


<div class="sources-list">
<strong>Sources</strong>
<ul>
<li>massive.com: company profile &amp; branding, technical indicators, headlines (5 items)</li>
<li>yfinance: prices &amp; technicals, fundamentals, earnings calendar</li>
<li>Google Custom Search: core business, product portfolio, profitability, earnings trend, target customers, market segments, competitors, market share, rumors, tariffs news, latest rumor, tariff impact</li>
<li>The Guardian: business model, profit outlook, market expansion, competitive landscape, rumor, tariff, latest news, tariffs</li>
</ul>
</div>


<details class="cli-log">
<summary>Show generation log^</summary>
<pre><code>
Gathering context for MRNA...
Gathering market data...
Checking massive.com quota and fetching price history...
Requesting MRNA prices from massive.com... (https://api.massive.com/v2/aggs/ticker/MRNA/range/1/day/2020-10-17/2025-11-15?adjusted=true&amp;sort=asc&amp;limit=5000&amp;apiKey=%2A%2A%2A)
massive.com request failed (massive.com returned no price data); switching to yfinance...
Requesting prices from yfinance fallback...
Price data acquired from yfinance.
Massive open-close: GET https://api.massive.com/v1/open-close/MRNA/2025-11-14?apiKey=%2A%2A%2A
Massive open-close: response 200 from https://api.massive.com/v1/open-close/MRNA/2025-11-14?apiKey=&lt;redacted&gt;
Massive previous close: GET https://api.massive.com/v2/aggs/ticker/MRNA/prev?adjusted=true&amp;apiKey=%2A%2A%2A
Massive previous close: response 200 from https://api.massive.com/v2/aggs/ticker/MRNA/prev?adjusted=true&amp;apiKey=&lt;redacted&gt;
Massive SMA: GET https://api.massive.com/v1/indicators/sma/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
Massive SMA: response 200 from https://api.massive.com/v1/indicators/sma/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
Massive EMA: GET https://api.massive.com/v1/indicators/ema/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
Massive EMA: response 200 from https://api.massive.com/v1/indicators/ema/MRNA?timespan=day&amp;window=50&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
Massive MACD: GET https://api.massive.com/v1/indicators/macd/MRNA?timespan=day&amp;series_type=close&amp;fast=12&amp;slow=26&amp;signal=9&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
Massive MACD: response 429 from https://api.massive.com/v1/indicators/macd/MRNA?timespan=day&amp;series_type=close&amp;fast=12&amp;slow=26&amp;signal=9&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
Massive RSI: GET https://api.massive.com/v1/indicators/rsi/MRNA?timespan=day&amp;window=14&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=%2A%2A%2A
Massive RSI: response 429 from https://api.massive.com/v1/indicators/rsi/MRNA?timespan=day&amp;window=14&amp;series_type=close&amp;order=desc&amp;limit=1&amp;adjusted=true&amp;apiKey=&lt;redacted&gt;
Calculating technical snapshot...
Fetching company profile (massive.com)...
Massive profile: GET https://api.massive.com/v3/reference/tickers/MRNA?apiKey=%2A%2A%2A
Massive profile: response 200 from https://api.massive.com/v3/reference/tickers/MRNA?apiKey=&lt;redacted&gt;
Massive profile: company metadata retrieved successfully.
Massive logo: using cached asset /home/runner/work/stonks/stonks/assets/logos/MRNA.svg
Massive related companies: GET https://api.massive.com/v1/related-companies/MRNA?apiKey=%2A%2A%2A
Massive related companies: response 200 from https://api.massive.com/v1/related-companies/MRNA?apiKey=&lt;redacted&gt;
Massive related companies: retrieved 10 entries.
Fetching company fundamentals...
Retrieving earnings calendar...
Massive earnings: attempting request with key 2QGS***XN
Massive earnings: GET https://api.massive.com/benzinga/v1/earnings?ticker=MRNA&amp;limit=4&amp;apiKey=%2A%2A%2A
Massive earnings: response 403 from https://api.massive.com/benzinga/v1/earnings?ticker=MRNA&amp;limit=4&amp;apiKey=&lt;redacted&gt;
Massive earnings: access denied (403) - You are not entitled to this data. Please upgrade your plan at https://polygon.io/pricing
Assembling quick facts...
Collecting latest headlines (massive.com)...
Massive news: GET https://api.massive.com/v2/reference/news?ticker=MRNA&amp;limit=5&amp;order=desc&amp;apiKey=%2A%2A%2A
Massive news: response 200 from https://api.massive.com/v2/reference/news?ticker=MRNA&amp;limit=5&amp;order=desc&amp;apiKey=&lt;redacted&gt;
Massive news: collected 5 articles.
  massive.com returned 5 headlines
Running supplementary searches...
  google_custom_search search -&gt; MRNA core business (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+core+business&amp;num=5
    google_custom_search: 5 result(s)
  google_custom_search search -&gt; MRNA product portfolio (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+product+portfolio&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA business model (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+business+model&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA business model&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+business+model&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA business model&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+business+model&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA profitability (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+profitability&amp;num=5
    google_custom_search: 5 result(s)
  google_custom_search search -&gt; MRNA earnings trend (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+earnings+trend&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA profit outlook (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+profit+outlook&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA profit outlook&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+profit+outlook&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA profit outlook&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+profit+outlook&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA target customers (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+target+customers&amp;num=5
    google_custom_search: 5 result(s)
  google_custom_search search -&gt; MRNA market segments (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+market+segments&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA market expansion (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+market+expansion&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA market expansion&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+market+expansion&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA market expansion&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+market+expansion&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA competitors (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+competitors&amp;num=5
    google_custom_search: 5 result(s)
  google_custom_search search -&gt; MRNA market share (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+market+share&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA competitive landscape (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+competitive+landscape&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA competitive landscape&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+competitive+landscape&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA competitive landscape&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+competitive+landscape&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA rumors (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+rumors&amp;num=5
    google_custom_search: 5 result(s)
  google_custom_search search -&gt; MRNA tariffs news (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+tariffs+news&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA rumor (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+rumor&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA rumor&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+rumor&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA rumor&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+rumor&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  newsapi search -&gt; MRNA tariff (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+tariff&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA tariff&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+tariff&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA tariff&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+tariff&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  newsapi search -&gt; MRNA latest news (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+latest+news&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA latest news&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+latest+news&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA latest news&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+latest+news&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA latest rumor (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+latest+rumor&amp;num=5
    google_custom_search: 5 result(s)
  newsapi search -&gt; MRNA tariffs (priority: newsapi, gnews, guardian)
NewsAPI search: GET https://newsapi.org/v2/everything?q=MRNA+tariffs&amp;pageSize=5&amp;language=en&amp;sortBy=publishedAt&amp;apiKey=%2A%2A%2A
NewsAPI search failed for &#x27;MRNA tariffs&#x27;: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
GNews search: GET https://gnews.io/api/v4/search?q=MRNA+tariffs&amp;lang=en&amp;max=5&amp;token=%2A%2A%2A
GNews search failed for &#x27;MRNA tariffs&#x27;: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
Guardian search: GET https://content.guardianapis.com/search?q=MRNA+tariffs&amp;api-key=%2A%2A%2A&amp;page-size=5&amp;order-by=newest&amp;show-fields=trailText
    newsapi: error: 429 Client Error: Too Many Requests for url: https://newsapi.org/v2/everything
    gnews: error: 403 Client Error: Forbidden for url: https://gnews.io/api/v4/search
    guardian: 5 result(s)
  google_custom_search search -&gt; MRNA tariff impact (priority: google_custom_search, newsapi, gnews, guardian)
Google Custom Search: GET https://www.googleapis.com/customsearch/v1?key=%2A%2A%2A&amp;cx=46c4e3bbc6b31470f&amp;q=MRNA+tariff+impact&amp;num=5
    google_custom_search: 5 result(s)
Synthesizing narrative from OpenAI response...
Preparing OpenAI request...
Dispatching bullets to OpenAI:
  - 0.1 Long Entry? [Lead with &#x27;yes&#x27;, &#x27;no&#x27;, or &#x27;maybe&#x27;, then cite specific historical positioning, macro froth cues (or lack thereof), and placement relative to moving averages or support/resistance.]
  - 1.1 Activities
  - 1.2 Profitable?
  - 1.3 Customer &amp; Markets
  - 1.4 Competition
  - 2.1 7d Trend?
  - 2.2 7d Buy/Sell Points?
  - 2.3.1 7d Volume
  - 2.3.2 7d Volatility
  - 3.1 Stability?
  - 3.2 Innovating?
  - 4.1 News
  - 4.2 Tarrifs
Asking OpenAI for analysis...
Received response from OpenAI.
</code></pre>
</details>
